Teaming Up to Manage Patients with COPD: A Game Plan to Streamline CarePremiere Date: Wednesday, August 21, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
|Fernando J. Martinez, MD, MS (Moderator)
Chief, Pulmonary and Critical Care Medicine
Bruce Webster Professor of Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY
|MeiLan K. Han, MD, MS
Professor of Internal Medicine
Director, Michigan Airways Program
Division of Pulmonary and Critical Care Medicine
University of Michigan Health System
Ann Arbor, MI
|Matthew L. Mintz, MD, FACP
Clinical Associate Professor of Medicine
The George Washington University School of Medicine
The burden of chronic obstructive pulmonary disease (COPD) has grown substantially in the last several decades, and while the management paradigm for COPD continues to evolve, the treatment of COPD remains inadequate. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) consistently updates management guidelines to reflect the latest advances and inform treatment selection; however, adherence to guidelines is suboptimal. This often leads to comorbidities being under appreciated, inappropriate treatment selection, and poor communication among members of the care team.
This CME Outfitters webcast features both pulmonology and primary care physicians and utilizes an interactive, animated 3-D model of the lung to help bridge the knowledge gap regarding evolving COPD guidelines and optimal treatment.
At the end of this CE activity, participants should be able to:
- Apply evidence-based treatment guidelines to treatment decisions for patients with COPD.
- Select inhaled maintenance treatment for patients with COPD based on various factors including clinical evidence, delivery device, symptomatology, and exacerbation risk.
- Employ multidisciplinary approaches to optimize the continuity of care between primary care practice and pulmonology clinics for patients with COPD.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe evidence-based treatment guidelines for treatment decisions for patients with COPD.
- Identify inhaled maintenance treatment for patients with COPD based on various factors including clinical evidence, delivery device, symptomatology, and exacerbation risk.
- Describe multidisciplinary approaches to optimize the continuity of care between primary care practice and pulmonology clinics for patients with COPD.
This educational activity is supported by an educational grant from GlaxoSmithKline.
Pulmonologists, primary care physicians, nurse practitioners, physician assistants, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Martinez reports he received research support from Bayer Corporation; Biogen; Merck & Co., Inc.; Nitto BioPharma, Inc.; Promedior, Inc.; Prometic Life Sciences Inc. and Respivant Sciences, Inc. He is a consultant for AstraZeneca; Boehringer Ingelheim; Chiesi USA, Inc.; Gala Pharmaceutical Inc.; Genentech, Inc.; GlaxoSmithKline; ProterixBio, Inc.; Sunovion Pharmaceuticals Inc. and Teva Pharmaceuticals.
Dr. Han reports that she received research support from Novartis Pharmaceuticals Corporation and Sunovion Pharmaceuticals Inc. She is a consultant for AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; and Mylan Inc.
Dr. Mintz reports that he is a consultant for Boehringer Ingelheim; and GlaxoSmithKline. He is on the speakers bureau for Boehringer Ingelheim; and GlaxoSmithKline.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).